Prognostic value of adenosine deaminase compared to other markers for progression to acquired immunodeficiency syndrome among intravenous drug users
- 1 February 1995
- journal article
- clinical trial
- Published by Wiley in Journal of Medical Virology
- Vol. 45 (2) , 203-210
- https://doi.org/10.1002/jmv.1890450216
Abstract
This study was designed to determine the prognostic value of erythrocyte adenosine deaminase (ADA) as a possible indicator of progression to AIDS, and compare this with other known cellular and serological markers. At the end of a 3‐year study, a cohort of 114 human immunodeficiency virus‐1 (HIV‐1) seropositive intravenous drug users (IVDUs) from the five different Center for Disease Control (CDC) groups was examined in order to estimate the prognostic relevance with respect to the progression to acquired immunodeficiency syndrome (AIDS) of each of the following markers at baseline value: number and percentage of CD4+T cells, number of CD8+T cells, CD4+/CD8+ratio, IgA and β2microglobulin and ADA levels, and the presence of HIV antigens. Moreover, 57 IVDUs belonging to II and III CDC groups were analyzed in a follow‐up study at 6‐month intervals, in order to evaluate and compare the behavior of each marker over time. The prognostic significance of each marker was assessed by computing the survival distribution and the Cox analysis in a multivariate model providing the set of markers with greatest predictive value. The levels of ADA and the CD4+/CD8+ratio showed a linear association with disease staging, whereas β2microglobulin and CD4+/ CD8+ratio were the best predictors for AIDS progression. A highly significant increase in ADA and β2microglobulin was observed during follow‐up. The results obtained among HIV‐positive IVDUs clearly indicate that the erythrocyte ADA may be considered a reliable marker of the development of HIV infection from the intermediate stages of the disease onwards. The measurement of β2microglobulin should be regarded as a particularly useful parameter in the assessment of HIV infection in drug users.Keywords
This publication has 28 references indexed in Scilit:
- CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual menAIDS, 1991
- CD8+ T lymphocytes and progression to AIDS in HIV-infected menAIDS, 1991
- Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug usersAIDS, 1990
- Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudineAIDS, 1990
- The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Prognostic significance of adenosine deaminase determinations in subjects with the lymphoadenopathy syndromeJournal of Medical Virology, 1988
- Long-Term Evaluation of HIV Antigen and Antibodies to p24 and gp41 in Patients with HemophiliaNew England Journal of Medicine, 1987
- Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.BMJ, 1987
- Activity of Adenosine Deaminase in Cerebrospinal Fluid for the Diagnosis and Follow-Up of Tuberculous Meningitis in AdultsThe Journal of Infectious Diseases, 1987
- Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.Proceedings of the National Academy of Sciences, 1986